Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Jeffrey V. Lazarus, Henry E. Mark, Marcela Villota‐Rivas, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 771-780
Open Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Zobair M. Younossi, Pegah Golabi, James M. Paik, et al.
Hepatology (2023) Vol. 77, Iss. 4, pp. 1335-1347
Open Access | Times Cited: 1472
Principal component analysis
Michael Greenacre, Patrick J. F. Groenen, Trevor Hastie, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Closed Access | Times Cited: 583
Changing epidemiology, global trends and implications for outcomes of NAFLD
Vincent Wai‐Sun Wong, Mattias Ekstedt, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 842-852
Open Access | Times Cited: 304
Current status and future trends of the global burden of MASLD
Lei Miao, Giovanni Targher, Christopher D. Byrne, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 697-707
Closed Access | Times Cited: 219
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world
Linda Henry, James M. Paik, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 6, pp. 942-956
Closed Access | Times Cited: 145
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 764-783
Closed Access | Times Cited: 99
Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
Alina M. Allen, Jeffrey V. Lazarus, Zobair M. Younossi
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 209-217
Open Access | Times Cited: 90
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Terry Cheuk‐Fung Yip, Eduardo Vilar‐Gómez, Salvatore Petta, et al.
Hepatology (2022) Vol. 77, Iss. 4, pp. 1404-1427
Closed Access | Times Cited: 80
A global research priority agenda to advance public health responses to fatty liver disease
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 618-634
Open Access | Times Cited: 72
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
Wayne Eskridge, Donna R. Cryer, Jörn M. Schattenberg, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6216-6216
Open Access | Times Cited: 44
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies
Michail Kokkorakis, Emir Muzurović, Špela Volčanšek, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 3, pp. 454-499
Open Access | Times Cited: 35
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019
Pojsakorn Danpanichkul, Kanokphong Suparan, Priyata Dutta, et al.
Metabolism (2024) Vol. 158, pp. 155958-155958
Closed Access | Times Cited: 29
Incidence of liver cancer in young adults according to the Global Burden of Disease database 2019
Pojsakorn Danpanichkul, Majd B. Aboona, Banthoon Sukphutanan, et al.
Hepatology (2024) Vol. 80, Iss. 4, pp. 828-843
Closed Access | Times Cited: 23
Liver Cancer in 2021: Global Burden of Disease Study
En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 22
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai–Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 10
"Evolving epidemiology of HCC in Spain"
Margarita Sala, Sonia Pascual, Montserrat Roca, et al.
JHEP Reports (2025), pp. 101336-101336
Open Access | Times Cited: 3
Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
Meijing Chen, Ying Chen, Jin-qing Lin, et al.
Frontiers in Nutrition (2025) Vol. 11
Open Access | Times Cited: 2
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 790-801
Open Access | Times Cited: 56
Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals
Jingxuan Quek, Cheng Han Ng, Ansel Shao Pin Tang, et al.
Endocrine Practice (2022) Vol. 28, Iss. 7, pp. 667-672
Closed Access | Times Cited: 54
Management of NAFLD in primary care settings
Vincent Wai‐Sun Wong, Shira Zelber‐Sagi, Kenneth Cusi, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2377-2389
Closed Access | Times Cited: 54
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
Luis Antonio Díaz, Eduardo Fuentes‐López, Gustavo Ayares, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 7, Iss. 6, pp. 552-559
Open Access | Times Cited: 50
An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Timothy J. Kendall, Maria Jiménez Ramos, Frances Turner, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2939-2953
Open Access | Times Cited: 37
A global action agenda for turning the tide on fatty liver disease
Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 502-523
Open Access | Times Cited: 36
Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
Pei Chia Eng, Roberta Forlano, Tricia Tan, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100835-100835
Open Access | Times Cited: 35
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Giandomenico Bisaccia, Fabrizio Ricci, Mohammed Y Khanji, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 6, pp. 101643-101643
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top